Dr Lal PathLabs Q4 Results: Diagnostics company Dr Lal PathLabs on Friday reported a consolidated net profit of Rs 84.5 crore for the January-March period, an increase of 49 per cent compared with the corresponding period a year ago. The opening of new labs and growing demand for medical tests boosted the company’s profitability.
The New Delhi-headquartered firm registered year-on-year growth of 11.1 per cent in revenue to Rs 545.4 crore for the quarter ended March 31, 2024, according to a regulatory filing.
Dr Lal PathLabs shares jumped after the earnings announcement, closing stranger by Rs 119.9, or 5.4 per cent, for the day at Rs 2,348.9 apiece on BSE.
(This story will be updated shortly)
Catch all the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.
Doonited Affiliated: Syndicate News Hunt
This report has been published as part of an auto-generated syndicated wire feed. Except for the headline, the content has not been modified or edited by Doonited
